Cite
HARVARD Citation
Hatano, E. et al. (2015). Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K‐ras status for unresectable colorectal liver metastasis (BECK study). Journal of hepato-biliary-pancreatic sciences. pp. 634-645. [Online].